ScholarIQanswers from OpenAlex & ORCID
Izumi Ohno
ResearcherPublications, citations & collaboration network
Izumi Ohno is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Izumi Ohno have?
ScholarIQindexed works
Izumi Ohno has 263 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Izumi Ohno have?
ScholarIQcitation count
Izumi Ohno has 4,596 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Izumi Ohno?
ScholarIQh-index
Izumi Ohno has an h-index of 24 in OpenAlex.
What is the i10-index of Izumi Ohno?
ScholarIQi10-index
Izumi Ohno has an i10-index of 56 in OpenAlex.
What is the ORCID of Izumi Ohno?
ScholarIQorcid
The ORCID for Izumi Ohno is on the source record.
What is the OpenAlex record for Izumi Ohno?
ScholarIQopenalex
The OpenAlex for Izumi Ohno is on the source record.
What are the most-cited papers on Izumi Ohno?
ScholarIQmost cited works
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun‐Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean‐Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo Abada, Masatoshi Kudo
Nivolumab alone or in combination with cisplatin plus gemcitabine in Japanese patients with unresectable or recurrent biliary tract cancer: a non-randomised, multicentre, open-label, phase 1 study
Makoto Ueno, Masafumi Ikeda, Chigusa Morizane, Satoshi Kobayashi, Izumi Ohno, Shunsuke Kondo, Naohiro Okano, Keisuke Kimura, Suguru Asada, Yoshinobu Namba, Takuji Okusaka, Junji Furuse
Anodic Oxidation of Reductants in Electroless Plating
Izumi Ohno, Osamu Wakabayashi, Shirō Haruyama
Electrochemistry of electroless plating
Izumi Ohno
Serum levels of IL-6 and IL-1β can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer
Shuichi Mitsunaga, Masafumi Ikeda, Satoshi Shimizu, Izumi Ohno, J. Furuse, Masatoshi Inagaki, Sayumi Higashi, Hiroyuki Kato, Keiji Terao, Atsushi Ochiai